Circulating procoagulant microparticles in cancer patients

Annals of Hematology

Volumn 90, Issue 4, 2011, Pages 447-453

  Thaler, Johannes ^a   Ay, Cihan ^a   Weinstabl, Harald ^a   Dunkler, Daniela ^a   Simanek, Ralph ^a   Vormittag, Rainer ^a   Freyssinet, Jean Marie ^b   Zielinski, Christoph ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cancer; Microparticles; Prothrombinase assay; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 10A; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROCOAGULANT; COAGULATING AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE MICROPARTICLE; OBSERVATIONAL STUDY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM; BLOOD; METABOLISM; MIDDLE AGED; NEOPLASM; RISK FACTOR;

AGED; CELL-DERIVED MICROPARTICLES; COAGULANTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79955941687     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1111-1     Document Type: Article

References (44)

1. Siljander P, Carpen O, Lassila R (1996) Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87I:4651-4663 (Pubitemid 26162364)
2. Willekens FL, Werre JM, Groenen-Dopp YA et al (2008) Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 141I:549-556
3. Sabatier F, Roux V, Anfosso F et al (2002) Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99I:3962-3970 (Pubitemid 35332035)
4. Diamant M, Tushuizen ME, Sturk A et al (2004) Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 34I:392-401
5. Satta N, Freyssinet JM, Toti F (1997) The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol 96I:534-542 (Pubitemid 27087240)
6. Schecter AD, Spirn B, Rossikhina M et al (2000) Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87I:126-132 (Pubitemid 30616908)
7. Hugel B, Martinez MC, Kunzelmann C et al (2005) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20I:22-27 (Pubitemid 40363367)
8. Falati S, Liu Q, Gross P et al (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle p-selectin glycoprotein ligand 1 and platelet p-selectin. J Exp Med 197I:1585-1598 (Pubitemid 36682554)
9. Del Conde I, Bharwani LD, Dietzen DJ et al (2007) Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5I:70-74 (Pubitemid 44921069)
10. Zwicker JI, Liebman HA, Neuberg D et al (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15I:6830-6840
11. Morel O, Toti F, Hugel B et al (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26I:2594-2604
12. Polgar J, Matuskova J, Wagner DD (2005) The p-selectin, tissue factor, coagulation triad. J Thromb Haemost 3I:1590-1596 (Pubitemid 41716543)
13. Tesselaar ME, Romijn FP, Van Der Linden IK et al (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5I:520-527
14. Chirinos JA, Heresi GA, Velasquez H et al (2005) Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45I:1467-1471 (Pubitemid 40615620)
15. Ay C, Freyssinet JM, Sailer T et al (2009) Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 123I:724-726
16. Heit JA, Silverstein MD, Mohr DN et al (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160I:809-815 (Pubitemid 30165241)
17. Blom JW, Doggen CJ, Osanto S et al (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293I:715-722 (Pubitemid 40216041)
18. Sousou T, Khorana A (2009) Identifying cancer patients at risk for venous thromboembolism. Hamostaseologie 29I:121-124
19. Toth B, Liebhardt S, Steinig K et al (2008) Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 100I:663-669
20. Kim HK, Song KS, Park YS et al (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39I:184-191 (Pubitemid 36057068)
21. Sud R, Khorana AA (2009) Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model. Thromb Res 123(Suppl 4I):S18-S21
22. Langer F, Spath B, Haubold K, Holstein K, Marx G, Wierecky J, Brümmendorf TH, Dierlamm J, Bokemeyer C, Eifrig B (2008) Tissue factor procoagulant activity of plasmamicroparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol 87I:451-457
23. Ay C, Simanek R, Vormittag R et al (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112I:2703-2708
24. Vormittag R, Simanek R, Ay C et al (2009) High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol 29I:2176-2181
25. Ay C, Vormittag R, Dunkler D et al (2009) D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27I:4124-4129
26. Aupeix K, Hugel B, Martin T et al (1997) The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99I:1546-1554 (Pubitemid 27163805)
27. Pigault C, Follenius-Wund A, Schmutz M et al (1994) Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol 236I:199-208 (Pubitemid 24148958)
28. Stewart JC (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104I:10-14
29. Hron G, Kollars M, Weber H et al (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97I:119-123 (Pubitemid 46242392)
30. Kakkar AK, Levine M, Pinedo HM et al (2003) Venous thrombosis in cancer patients: insights from the frontline survey. Oncologist 8I:381-388 (Pubitemid 36929723)
31. Jenkins EO, Schiff D, Mackman N et al (2010) Venous thromboembolism in malignant gliomas. J Thromb Haemost 8:221-227
32. Simanek R, Vormittag R, Hassler M et al (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol 9I:89-95 (Pubitemid 46580310)
33. Semrad TJ, O'Donnell R, Wun T et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106I:601-608 (Pubitemid 46536455)
34. Rong Y, Post DE, Pieper RO et al (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 65:1406-1413 (Pubitemid 40270169)
35. Jy W, Horstman LL, Jimenez JJ et al (2004) Measuring circulating cell-derived microparticles. J Thromb Haemost 2I:1842-1851 (Pubitemid 40197488)
36. Abid Hussein MN, Boing AN, Biro E et al (2008) Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res 121I:865-871 (Pubitemid 351491289)
37. Biro E, Akkerman JW, Hoek FJ et al (2005) The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost 3I:2754-2763 (Pubitemid 41819805)
38. Weerheim AM, Kolb AM, Sturk A et al (2002) Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal Biochem 302I:191-198 (Pubitemid 34229723)
39. Nieuwland R, Berckmans RJ, McGregor S et al (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95I:930-935 (Pubitemid 30063043)
40. Sabatier F, Darmon P, Hugel B et al (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51I:2840-2845 (Pubitemid 34970939)
41. Mallat Z, Benamer H, Hugel B et al (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101I:841-843 (Pubitemid 30117876)
42. Manly DA, Wang J, Glover SL et al (2009) Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 125I:511-512
43. Gonzalez-Quintero VH, Jimenez JJ, Jy W et al (2003) Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 189I:589-593
44. Valeri CR, Ragno G, Khuri S (2005) Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing. Transfusion 45I:1890-1898 (Pubitemid 43971415)